Zhong Qi Shao
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Zhong Qi Shao is a Member-Supervisory Board & VP-Vaccine Research at CanSino Biologics, Inc. He previously worked as a Principal at BioMarin Pharmaceutical, Inc. and as a Senior Scientist at Sanofi.
He holds a doctorate degree from Concordia University, which he obtained in 1993.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2024 | 675.000 ( 0,51 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CANSINO BIOLOGICS INC. | Director/Miembro de la Junta | 28/05/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
| SANOFI | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CanSino Biologics, Inc.
CanSino Biologics, Inc. BiotechnologyHealth Technology Manufactures and commercializes vaccines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition